You are here

Coronavirus (COVID-19): Information on medicines and medical devices

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.

Please read the information below before contacting the TGA to see if your question is already answered.

Filters
16 April 2021
Third Australian case of thrombosis with thrombocytopenia likely linked to vaccine
14 April 2021
The granting of a provisional determination means that the TGA has made a decision that GSK is now eligible to apply for provisional registration for the treatment in the Australian Register of Therapeutic Goods.
14 April 2021

COVID-19 vaccine batch release information is now available.

13 April 2021
Second case of thrombosis with thrombocytopenia
9 April 2021
Updated safety advisory – rare and unusual blood clotting syndrome (thrombosis with thrombocytopaenia)
8 April 2021
Updated storage conditions for the Pfizer COVID-19 vaccine
8 April 2021
The TGA is undertaking a post-market review of all face masks included in the Australian Register of Therapeutic Goods to ensure the quality and effectiveness of face masks.
8 April 2021
A list of tests approved for inclusion in the Australian Register of Therapeutic Goods (ARTG)
6 April 2021
The TGA is undertaking a post-market review of face masks included in the ARTG. This page lists all face masks that have been cancelled from the ARTG during the review.
2 April 2021
Australia’s vaccine safety and regulatory process is world class and people can be confident that vaccines approved for use are safe and effective.

Pages

Further information

Contact TGA Info

Tel: 1800 020 653
Email: info@tga.gov.au

Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.

Department of Health

Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.

Follow us